Company Information
USD
17.44
- (4.7%)
NASDAQ:NVCR, NOVOCURE LIMITED
Industry: Medical Devices
End of Day: 8 May 2025 GMT-4
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Address
Grenville Street
No. 4 The Forum, Second Floor
Website
Classification
Sector
Healthcare
Industry Group
Medical Devices & Instruments
Industry
Medical Devices
Key Executives
Mr. Frank Leonard
Executive VP/President
Dr. Nicholas Leupin, M.D.,PhD
Chief Medical Officer
Mr. Timothy John Scannell
Director
Mr. William F. Doyle
Chairman of the Board/Director
Mr. Wilhelmus C. M. Groenhuysen
COO
Dr. David T. Hung,M.D.
Director
Ms. Jeryl L. Hilleman
Director
Mr. Kinyip Gabriel Leung
Director
Mr. Asaf Danziger
CEO/Director
Mr. William A. Vernon
Director
Mr. Martin J. Madden
Director
Dr. Uri Weinberg, M.D.,PhD
Other Executive Officer
Ms. Ashley Cordova
CFO/Chief Accounting Officer
Ms. Kristin Stafford, C.P.A.
Director
Dr. Allyson J. Ocean, M.D.
Director
Mr. Moshe Giladi
Chief Scientific Officer
Mr. Michae Puri
Other Executive Officer
Ownership
Institution Holdings
FMR Inc
15,962,767 (14.905%)
FMR LLC
15,743,514 (14.733%)
Capital Research and Management Company
11,677,275 (10.904%)
Vanguard Group Inc
9,759,098 (9.113%)
Capital Research & Mgmt Co - Division 3
8,861,871 (8.275%)
BlackRock Inc
8,792,035 (8.210%)
CAPITAL INTERNATIONAL INVESTORS
8,155,909 (7.632%)
Fidelity Management & Research Company LLC
7,907,183 (7.383%)
Fidelity Management Trust Company
6,778,509 (6.330%)
Capital Group
6,381,511 (5.959%)
Individual Holdings
Mr. William F. Doyle
551,176 (0.526%)
Mr. Wilhelmus C. M. Groenhuysen
251,235 (0.235%)
Ms. Ashley Cordova
219,867 (0.205%)
Dr. Uri Weinberg, M.D.,PhD
171,148 (0.160%)
Mr. Frank Leonard
160,098 (0.150%)
Mr. Michal Nath Puri
109,167 (0.102%)
Mr. Moshe Giladi
69,771 (0.065%)
Dr. Nicholas Leupin, M.D.,PhD
51,124 (0.048%)
Mr. Martin J. Madden
14,806 (0.015%)
Mr. Asaf Danziger
13,989 (0.013%)
Funds Holdings
Fidelity Growth Company Commingled Pool
6,778,509 (6.330%)
Fidelity Growth Company Fund
4,996,175 (4.665%)
American Funds SMALLCAP World Fund
4,014,886 (3.749%)
Vanguard US Total Market Shares ETF
3,386,602 (3.162%)
Vanguard Total Stock Market Index Fund
3,386,602 (3.162%)
Vanguard Small Cap Index
2,728,904 (2.548%)
Fidelity Growth Company K6 Fund
1,802,975 (1.684%)
T. Rowe Price Health Sciences Fund
1,542,682 (1.441%)
Vanguard Institutional Extnd Mkt Idx Tr
1,440,699 (1.345%)
Vanguard Small Cap Growth Index Fund
1,340,302 (1.252%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
